Rosenberg Matthew Hamilton lifted its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 14.4% during the fourth quarter, Holdings Channel reports. The institutional investor owned 658 shares of the medical research company’s stock after buying an additional 83 shares during the quarter. Rosenberg Matthew Hamilton’s holdings in Thermo Fisher Scientific were worth $343,000 at the end of the most recent reporting period.
Several other large investors have also bought and sold shares of TMO. Signal Advisors Wealth LLC lifted its stake in Thermo Fisher Scientific by 18.3% during the fourth quarter. Signal Advisors Wealth LLC now owns 1,210 shares of the medical research company’s stock valued at $630,000 after buying an additional 187 shares in the last quarter. BCS Wealth Management acquired a new stake in shares of Thermo Fisher Scientific during the fourth quarter valued at approximately $218,000. Granite Bay Wealth Management LLC purchased a new stake in shares of Thermo Fisher Scientific in the 4th quarter valued at approximately $4,758,000. Benson Investment Management Company Inc. grew its position in Thermo Fisher Scientific by 0.7% during the 4th quarter. Benson Investment Management Company Inc. now owns 8,149 shares of the medical research company’s stock worth $4,239,000 after purchasing an additional 53 shares in the last quarter. Finally, Signet Financial Management LLC acquired a new stake in Thermo Fisher Scientific during the 4th quarter valued at $218,000. Institutional investors own 89.23% of the company’s stock.
Insider Transactions at Thermo Fisher Scientific
In related news, CEO Marc N. Casper sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $530.26, for a total value of $5,302,600.00. Following the completion of the transaction, the chief executive officer now owns 111,192 shares in the company, valued at $58,960,669.92. The trade was a 8.25 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Michael A. Boxer sold 2,000 shares of Thermo Fisher Scientific stock in a transaction on Friday, October 25th. The shares were sold at an average price of $560.16, for a total value of $1,120,320.00. Following the completion of the sale, the senior vice president now directly owns 12,736 shares of the company’s stock, valued at $7,134,197.76. This trade represents a 13.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 47,150 shares of company stock worth $25,954,465. Corporate insiders own 0.34% of the company’s stock.
Wall Street Analyst Weigh In
Read Our Latest Analysis on Thermo Fisher Scientific
Thermo Fisher Scientific Price Performance
Shares of Thermo Fisher Scientific stock opened at $555.91 on Tuesday. Thermo Fisher Scientific Inc. has a 1-year low of $493.30 and a 1-year high of $627.88. The firm’s 50-day moving average price is $529.92 and its two-hundred day moving average price is $568.10. The company has a current ratio of 1.63, a quick ratio of 1.26 and a debt-to-equity ratio of 0.64. The stock has a market capitalization of $212.64 billion, a price-to-earnings ratio of 34.85, a P/E/G ratio of 3.54 and a beta of 0.76.
Thermo Fisher Scientific (NYSE:TMO – Get Free Report) last issued its quarterly earnings data on Wednesday, October 23rd. The medical research company reported $5.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.25 by $0.03. The firm had revenue of $10.60 billion during the quarter, compared to the consensus estimate of $10.63 billion. Thermo Fisher Scientific had a return on equity of 17.49% and a net margin of 14.48%. The business’s revenue for the quarter was up .2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $5.69 EPS. On average, equities analysts predict that Thermo Fisher Scientific Inc. will post 21.68 earnings per share for the current fiscal year.
Thermo Fisher Scientific announced that its board has authorized a share buyback program on Friday, November 15th that allows the company to buyback $4.00 billion in shares. This buyback authorization allows the medical research company to purchase up to 2% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s board of directors believes its stock is undervalued.
Thermo Fisher Scientific Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Friday, December 13th will be given a $0.39 dividend. This represents a $1.56 annualized dividend and a yield of 0.28%. The ex-dividend date is Friday, December 13th. Thermo Fisher Scientific’s payout ratio is presently 9.78%.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Featured Articles
- Five stocks we like better than Thermo Fisher Scientific
- There Are Different Types of Stock To Invest In
- Cintas: Trade Uncertainty Creates a Buy-the-Dip Opportunity
- Top Stocks Investing in 5G Technology
- 3 Stocks to Benefit From China’s Rare Earth Export Ban on U.S.
- How to Invest in Insurance Companies: A Guide
- Why Goldman Sachs Just Upgraded These 3 Stocks and What It Means
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report).
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.